TDM-1 for HER2-positive advanced breast cancer-clinical practice experience at university hospital for tumors

Category Primary study
JournalLibri Oncologici
Year 2021
This article has no abstract
Epistemonikos ID: 2fcc9a2efb9ef20f774919f7bf80997b09dbc875
First added on: Feb 12, 2025